Detalles de la búsqueda
1.
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
N Engl J Med
; 389(22): 2039-2051, 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870976
2.
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
Jpn J Clin Oncol
; 54(4): 452-462, 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271158
3.
Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weight.
Cancer Sci
; 114(5): 2087-2097, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36704833
4.
Soluble interleukin-2 receptor as a predictive biomarker for poor efficacy of combination treatment with anti-PD-1/PD-L1 antibodies and chemotherapy in non-small cell lung cancer patients.
Invest New Drugs
; 41(3): 411-420, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058183
5.
EGFR-TKI re-administration after osimertinib failure in T790M mutation loss cases with re-biopsy.
Invest New Drugs
; 40(6): 1342-1349, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36152107
6.
Monitoring epidermal growth factor receptor C797S mutation in Japanese non-small cell lung cancer patients with serial cell-free DNA evaluation using digital droplet PCR.
Cancer Sci
; 112(6): 2371-2380, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33686722
7.
Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer.
Int J Clin Oncol
; 26(3): 507-514, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159605
8.
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase-positive non-small cell lung cancer and the clinical responses based on the resistant mechanisms.
Cancer Sci
; 111(3): 932-939, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31961053
9.
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors.
BMC Cancer
; 20(1): 207, 2020 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164651
10.
Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC.
Int J Clin Oncol
; 25(1): 67-73, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31506751
11.
The Design of and Rationale for the Effect of Perioperative Inhaled Tiotropium for Patients with Chronic Obstructive Pulmonary Disease in Esophageal Cancer Surgery (EPITOPE): an Open-Label, Randomized, Parallel-Group Study.
Eur Surg Res
; 61(4-5): 123-129, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32248190
12.
Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients.
Cancer Sci
; 110(10): 3350-3357, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31361375
13.
Phase Ia/Ib study of the pan-class I PI3K inhibitor pictilisib (GDC-0941) administered as a single agent in Japanese patients with solid tumors and in combination in Japanese patients with non-squamous non-small cell lung cancer.
Invest New Drugs
; 35(1): 37-46, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27565810
14.
Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib.
Anticancer Drugs
; 28(5): 565-567, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28225456
15.
Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene.
Jpn J Clin Oncol
; 47(12): 1189-1192, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28977547
16.
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with advanced solid tumors.
Invest New Drugs
; 34(1): 66-74, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26627079
17.
Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer.
Invest New Drugs
; 33(4): 881-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924991
18.
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
Invest New Drugs
; 33(3): 641-51, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25809858
19.
Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases.
Jpn J Clin Oncol
; 44(9): 835-40, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25097183
20.
Secondary osteosarcoma developing 10 years after chemoradiotherapy for non-small-cell lung cancer.
Jpn J Clin Oncol
; 44(2): 191-4, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24338556